NIAID | Technology Transfer

MVA Expressing Modified HIV Envelope, Gag And Pol Genes

Read more about MVA Expressing Modified HIV Envelope, Gag And Pol Genes

US Patent 8,916,172
Filed on 2011-01-11

METHODS FOR THE INDUCTION OF EBOLA VIRUS-SPECIFIC IMMUNE RESPONSES COMPRISING ADMINISTERING A REPLICATION-DEFECTIVE CHIMPANZEE ADENOVIRUS VECTOR EXPRESSING THE EBOLA VIRUS GLYCOPRETEIN

Read more about METHODS FOR THE INDUCTION OF EBOLA VIRUS-SPECIFIC IMMUNE RESPONSES COMPRISING ADMINISTERING A REPLICATION-DEFECTIVE CHIMPANZEE ADENOVIRUS VECTOR EXPRESSING THE EBOLA VIRUS GLYCOPRETEIN

US Patent 9,526,777
Filed on 2013-01-02

Chimpanzee Adenoviral Vector-Based Filovirus Vaccines

Read more about Chimpanzee Adenoviral Vector-Based Filovirus Vaccines

European Patent
11769662.5
Filed on 2011-04-15

Monoclonal Antibodies Against Dengue And Other Viruses With Deletion IN FC Region

Read more about Monoclonal Antibodies Against Dengue And Other Viruses With Deletion IN FC Region

US Application 13/722,275
Filed on 2012-12-20

Development Of Dengue Virus Vaccine Components

Read more about Development Of Dengue Virus Vaccine Components

US Patent 9,090,873
Filed on 2012-12-03

Monoclonal Antibodies That Bind Or Neutralize Dengue Virus

Read more about Monoclonal Antibodies That Bind Or Neutralize Dengue Virus

US Application 13/692,521
Filed on 2012-12-03

Method of Treating HIV Infection: Inhibition of DNA Dependent Protein Kinase

Read more about Method of Treating HIV Infection: Inhibition of DNA Dependent Protein Kinase

US Application 13/643,819
Filed on 2012-10-26

NEUTRALIZING GP41 ANTIBODIES AND THEIR USE

Read more about NEUTRALIZING GP41 ANTIBODIES AND THEIR USE

Patent Cooperation Treaty
PCT/US2012/063958
Filed on 2012-11-07

Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors

Canada
2793128
Filed on 2000-09-22

HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES

Read more about HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS BASED VACCINES

US Application 13/675,447
Filed on 2012-11-13

Subscribe to NIAID